Stevanato Group (NYSE:STVN) Sees Strong Trading Volume - Still a Buy?

Key Points

• Trading volume rose ~20% to 822,692 shares and the stock last traded at €14.58 (previous close €13.81), sitting just below its 50‑day average of €14.96 and well under its 200‑day average of €19.72.
• Analyst views are mixed — ratings range from Strong Buy to Sell but the consensus is a "Moderate Buy" amid several price‑target cuts (e.g., KeyCorp $37→$32, Citigroup $32→$26) and a Weiss downgrade to sell.
• Key fundamentals: market cap ~$4.45B, P/E 25.29, last quarter EPS €0.18 on €346.5M revenue, analysts forecast ~0.5 EPS for the year, and the company has low leverage (debt/equity 0.23) with decent liquidity ratios.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) saw an uptick in trading volume on Tuesday . 822,692 shares were traded during trading, an increase of 20% from the previous session's volume of 683,722 shares.The stock last traded at €14.58 and had previously closed at €13.81.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on STVN. Weiss Ratings downgraded Stevanato Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Wednesday, March 11th. Jefferies Financial Group set a $17.50 price objective on Stevanato Group in a research report on Tuesday, February 10th. Wall Street Zen cut Stevanato Group from a "buy" rating to a "hold" rating in a research report on Saturday, February 14th. KeyCorp dropped their target price on Stevanato Group from $37.00 to $32.00 and set an "overweight" rating on the stock in a research report on Thursday, March 5th. Finally, Citigroup dropped their target price on Stevanato Group from $32.00 to $26.00 and set a "buy" rating on the stock in a research report on Thursday, March 5th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy".

Stevanato Group Price Performance

The firm has a 50 day moving average price of €14.96 and a 200 day moving average price of €19.72. The company has a quick ratio of 1.26, a current ratio of 1.76 and a debt-to-equity ratio of 0.23. The stock has a market cap of $4.45 billion, a P/E ratio of 25.29, a P/E/G ratio of 1.21 and a beta of 0.62.

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings results on Saturday, February 14th. The company reported €0.18 EPS for the quarter. Stevanato Group had a return on equity of 10.44% and a net margin of 11.83%.The company had revenue of €346.50 million for the quarter. On average, analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

Institutional investors and hedge funds have recently modified their holdings of the stock. Farther Finance Advisors LLC purchased a new position in shares of Stevanato Group in the 3rd quarter worth approximately $44,000. GW&K Investment Management LLC boosted its holdings in shares of Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company's stock worth $49,000 after purchasing an additional 1,055 shares during the period. First Horizon Corp purchased a new position in shares of Stevanato Group in the 3rd quarter worth approximately $50,000. State of Wyoming boosted its holdings in shares of Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company's stock worth $58,000 after purchasing an additional 2,353 shares during the period. Finally, Quantbot Technologies LP purchased a new position in shares of Stevanato Group in the 3rd quarter worth approximately $68,000.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.